On March 9, Xie Bing, senior vice chairman of CP Group and founder of "China Biopharmaceutical", and his party visited Luoyang Modern Biotechnology Research Institute Co., Ltd. (hereinafter referred to as "Modern Biotechnology").
The participants also included Sui Xiaodong, Vice President of the New Business Department of CP Pharmaceutical Group, Chen Guang, Vice President of the New Business Department of CP Pharmaceutical Group, Lin Lijia, Secretary of the Chairman of CP Pharmaceutical Group, Li Fuqiang, Chairman of CP Jianlong Co., Ltd., Wang Chuang, Chief Engineer of CP Energy Co., Ltd., Tian Lei, Deputy General Manager of CP Jianlong, and Dong Ying, Chief Financial Officer of CP Jianlong. Wei Bin, Director of Luoyang Municipal Bureau of Industry and Information Technology, Yu Litao, Deputy Director of Luoyang Municipal Bureau of Industry and Information Technology, Wu Tao, Deputy Secretary of Luolong District Party Committee and Director of Luoyang Economic and Technological Development Zone, Zhang Hui, Director of Luolong District Bureau of Industry and Information Technology, and other leaders accompanied.
Mr. Wang Shanpu, Chairman of Modern Biotech, and Mr. Xie Bing had in-depth communication.
